Sign In
Buy MMSI
$67.27
+0.770 (+1.16%)
At Close: Jun 23, 2026
IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down
04:15pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.
Henry Schein (HSIC) Q3 Earnings In Line, 2022 Sales View Down
03:48pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Severe currency headwinds and lower sales of PPE and COVID-19 test kits affect Henry Schein's (HSIC) top line in Q3.
Teleflex (TFX) Q3 Earnings Top Estimates, Adjusted EPS View Cut
03:30pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
For UroLift, Teleflex (TFX) currently assumes 2022 revenues to be roughly $320 million, down from the prior guidance of $335 million.
Merit Medical Announces the Appointment of Joe Wright to Chief Commercial Officer
01:25pm, Tuesday, 01'st Nov 2022 GlobeNewswire Inc.
Merit’s long-time executive, Joe Wright, has been appointed to the new role of Chief Commercial Officer and will be responsible for leading all commercial activities for the global organization. Mer
Avantor (AVTR) Q3 Earnings Top Estimates, 2022 EPS View Cut
03:34pm, Monday, 31'st Oct 2022 Zacks Investment Research
Avantor's (AVTR) robust performance across the majority of its segments drives its Q3 sales, despite business challenges.
Integer Holdings (ITGR) Q3 Earnings Beat, 2022 View Lowered
04:48pm, Friday, 28'th Oct 2022 Zacks Investment Research
Integer Holdings' (ITGR) third-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.
DaVita (DVA) Q3 Earnings Lag Estimates, 2022 EPS View Cut
04:39pm, Friday, 28'th Oct 2022 Zacks Investment Research
DaVita's (DVA) Q3 performance gets a boost from strength in both its segments.
Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised
04:02pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.
Merit Medical (MMSI) Q3 Earnings Beat, FY22 View Revised
01:32pm, Thursday, 27'th Oct 2022
Merit Medical (MMSI), in the third quarter, benefits from revenue growth in both its segments and the majority of product categories within its Cardiovascular unit.
Merit Medical Systems, Inc. (MMSI) Fred Lampropoulos on Q3 2022 Results - Earnings Call Transcript
11:15pm, Wednesday, 26'th Oct 2022
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2022 Earnings Conference Call October 26, 2022 5:00 PM ET Company Participants Fred Lampropoulos - President & CEO Brian Lloyd - Chief Legal Officer & Cor
Merit Medical (MMSI) Q3 Earnings and Revenues Top Estimates
09:35pm, Wednesday, 26'th Oct 2022 Zacks Investment Research
Merit Medical (MMSI) delivered earnings and revenue surprises of 20.75% and 5.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Merit Medical (MMSI) Q3 Earnings and Revenues Top Estimates
06:49pm, Wednesday, 26'th Oct 2022
Merit Medical (MMSI) delivered earnings and revenue surprises of 20.75% and 5.18%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
04:19pm, Friday, 14'th Oct 2022 Zacks Investment Research
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio
01:33pm, Friday, 14'th Oct 2022
Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.
Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
01:25pm, Thursday, 13'th Oct 2022 GlobeNewswire Inc.
SOUTH JORDAN, Utah, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will re
